Muncy, Geissler, Olds & Lowe, P.C.
Pharmaceutical composition and kit for applying metformin and sodium butyrate in Kras mutation cancer treatment
A method for using metformin and sodium butyrate in combination to treat a cancer patient with K-ras mutation is disclosed. When administering the pharmaceutical composition to a cancer patient, Metformin and sodium butyrate offer cooperatively therapeutic efficacy. The present invention also discloses a pharmaceutical composition and a pharmaceutical kit containing both aforementioned. The application of the method, the pharmaceutical composition and the pharmaceutical kit of the present invention are advantageous for improving the treatment effect to cancer patients with K-ras mutation.
JOHNPRO BIOTECH INC.
A A A
A61P A61K A61K
inventional inventional inventional
Yu-Shan Chao-Chun Kwan-Hwa
Wang Chang Chi